Navigation Links
Can we afford the cancer care of the future?
Date:5/26/2009

ORLANDO (May 30, 2009)When a cancer patient and his or her doctor discuss the value of a treatment option, the conversation usually centers on a consideration of the treatment's medical benefits versus its possible side effects for the patient. Increasingly, however, as the already high costs of cancer care continue to rise, a full view of the patient's welfare must also take into account the economic impact of the treatment on the patient and his or her family.

Additionally, beyond its clear impact on patients, the increasing cost of cancer care also presents challenges to other stakeholders involved in the development and delivery of care.

"Cancer care is one of the most expensive areas of health care today, and the cost of that care is increasing steadily, for patients and for society as a whole," says Neal J. Meropol, M.D., director of the gastrointestinal cancer and gastrointestinal tumor risk assessment programs at Fox Chase Cancer Center. Meropol, who is also a member of the American Society of Clinical Oncology (ASCO) Cost of Care Task Force and lead author on the upcoming ASCO Guidance Statement on the Cost of Cancer Care, offered his analysis of the problem in a talk presented at the ASCO annual meeting in Orlando today.

"As physicians, we have a responsibility to understand the impact that the increasing cost of cancer care has on everyone involved," Meropol notes. "In particular, we need to be able to discuss with our patients the impact that high out-of-pocket expenses might have on them and their families, however difficult that conversation might be. More and more, cost considerations have an appropriate role in the assessment of treatment options."

According to Meropol, other stakeholders affected by the rising cost of cancer care in addition to patients include employers who must remain competitive while subsidizing their employees' health care, health insurance providers who must watch their bottom lines while deciding which treatments to pay for and at what level, physicians who must offer guidance for their patients in choosing among treatments, including new drugs that might offer modest survival benefits but at significant additional cost, and the pharmaceutical industry, which hopes to earn a profit from the sale of innovative drugs that can cost $1 billion to research and develop.

Meropol observes that many of the costly new cancer drugs now coming to market are highly targeted in their action, often quite effective but only in a subset of patients. While these drugs anticipate the dream of personalized medicine, their high costs must be shared over a smaller potential pool of patients, perhaps threatening the future of this promising new direction in medicine.

Rising costs also have the potential to widen the disparities that already exist in cancer outcomes among different populations, adding an ethical dimension to the problem.

"Rising costs may be a key impediment to reaching our societal goal of providing high quality cancer care to all citizens," Meropol says. Going forward, the challenges in confronting the cost-of-cancer-care issue are substantial. Patients and their physicians both feel ill-equipped to consider treatment costs in the clinical setting, and society has yet to address this multifaceted issue in a comprehensive way. Still, Meropol says, we have no alternative but to begin the search for answers now. The increasing economic burden posed by cancer-care costs on patients and their families and on society is too great to ignore.


'/>"/>

Contact: Frank Hoke
Franklin.Hoke@fccc.edu
215-475-2888
Fox Chase Cancer Center
Source:Eurekalert

Related medicine news :

1. Security Officers Who Protect Kaiser Hospitals Rally With Community Supporters for Access to Affordable Healthcare
2. UCSF creates fast, affordable tool for finding gene on-off switches
3. Affordable and Flexible CRM Solutions - Key to Drive Investments from Pharmaceutical Companies, Notes Frost & Sullivan
4. New Study Finds Fewer Families Can Afford Health Insurance
5. Security Officers Who Guard Kaiser Hospitals Protest Lack of Access to Affordable Healthcare
6. From Practical to Pampering: CVS/pharmacy Offers a Wide Selection of Department Store-Quality Gifts at Affordable Prices for Mothers Day
7. New Walmart Program Broadens Access to Affordable Prescriptions in Michigan
8. As Kaiser Permanente Opens a New Hospital Wing, Security Officers Left Behind Without Affordable Healthcare
9. Community Approach Necessary For Affordable Long-Term Care, Says NCB Capital Impact
10. Lesson From the States: Lack of Cost Controls Derailed California Health Reform, Led to Budget Overruns and Unaffordable Policies in Massachusetts
11. Deerfield Spa, the Northeasts Most Affordable Destination Spa, Now Offers Day Spa Getaways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: